| Dr Donald J Mcintire, MD | |
|
6781 E Us Highway 36 Ste 120, Avon, IN 46123 | |
| (317) 272-4685 | |
| Not Available |
| Full Name | Dr Donald J Mcintire |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 6781 E Us Highway 36 Ste 120, Avon, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316022189 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 01038641A (Indiana) | Primary |
| 208000000X | Pediatrics | 01038641 (Indiana) | Secondary |
| Entity Name | Indiana University Health Ball Memorial Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235455544 PECOS PAC ID: 9537072640 Enrollment ID: O20031110000505 |
News Archive
UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny 'biosensors' along with new advanced imaging techniques.
The rheumatoid arthritis treatment Humira will replace Lipitor as the world's biggest-selling drug in 2016, but a familiar name, Pfizer, will still be the biggest seller of medicines after the patent cliff according to the World Preview 2016 report published today by EvaluatePharma, the premier provider of pharma and biotech analysis.
Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
A large proportion of athletes with sports hernias also have femoroacetabular impingement of the hip on the same side of the body, results of a magnetic resonance imaging study show.
› Verified 1 days ago
| Entity Name | St Vincent Pediatric Subspecialties |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013967736 PECOS PAC ID: 1557313939 Enrollment ID: O20050214000627 |
News Archive
UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny 'biosensors' along with new advanced imaging techniques.
The rheumatoid arthritis treatment Humira will replace Lipitor as the world's biggest-selling drug in 2016, but a familiar name, Pfizer, will still be the biggest seller of medicines after the patent cliff according to the World Preview 2016 report published today by EvaluatePharma, the premier provider of pharma and biotech analysis.
Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
A large proportion of athletes with sports hernias also have femoroacetabular impingement of the hip on the same side of the body, results of a magnetic resonance imaging study show.
› Verified 1 days ago
| Entity Name | Deaconess Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619123585 PECOS PAC ID: 3375610116 Enrollment ID: O20080922000145 |
News Archive
UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny 'biosensors' along with new advanced imaging techniques.
The rheumatoid arthritis treatment Humira will replace Lipitor as the world's biggest-selling drug in 2016, but a familiar name, Pfizer, will still be the biggest seller of medicines after the patent cliff according to the World Preview 2016 report published today by EvaluatePharma, the premier provider of pharma and biotech analysis.
Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
A large proportion of athletes with sports hernias also have femoroacetabular impingement of the hip on the same side of the body, results of a magnetic resonance imaging study show.
› Verified 1 days ago
| Entity Name | St Vincent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144513375 PECOS PAC ID: 7012047640 Enrollment ID: O20100609000045 |
News Archive
UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny 'biosensors' along with new advanced imaging techniques.
The rheumatoid arthritis treatment Humira will replace Lipitor as the world's biggest-selling drug in 2016, but a familiar name, Pfizer, will still be the biggest seller of medicines after the patent cliff according to the World Preview 2016 report published today by EvaluatePharma, the premier provider of pharma and biotech analysis.
Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
A large proportion of athletes with sports hernias also have femoroacetabular impingement of the hip on the same side of the body, results of a magnetic resonance imaging study show.
› Verified 1 days ago
| Entity Name | Indiana University Health Urgent Care Centers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750763819 PECOS PAC ID: 0042526063 Enrollment ID: O20150904000941 |
News Archive
UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny 'biosensors' along with new advanced imaging techniques.
The rheumatoid arthritis treatment Humira will replace Lipitor as the world's biggest-selling drug in 2016, but a familiar name, Pfizer, will still be the biggest seller of medicines after the patent cliff according to the World Preview 2016 report published today by EvaluatePharma, the premier provider of pharma and biotech analysis.
Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
A large proportion of athletes with sports hernias also have femoroacetabular impingement of the hip on the same side of the body, results of a magnetic resonance imaging study show.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Donald J Mcintire, MD 6781 E Us Highway 36 Ste 120, Avon, IN 46123-9778 Ph: () - | Dr Donald J Mcintire, MD 6781 E Us Highway 36 Ste 120, Avon, IN 46123 Ph: (317) 272-4685 |
News Archive
UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny 'biosensors' along with new advanced imaging techniques.
The rheumatoid arthritis treatment Humira will replace Lipitor as the world's biggest-selling drug in 2016, but a familiar name, Pfizer, will still be the biggest seller of medicines after the patent cliff according to the World Preview 2016 report published today by EvaluatePharma, the premier provider of pharma and biotech analysis.
Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
A large proportion of athletes with sports hernias also have femoroacetabular impingement of the hip on the same side of the body, results of a magnetic resonance imaging study show.
› Verified 1 days ago
Ruth M Mccluskey, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8244 E Us Highway 36, Suite 210, Avon, IN 46123 Phone: 317-272-7337 Fax: 317-272-8534 | |
Amanda Melissa Gripe, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1111 Ronald Reagan Pkwy, B1100, Avon, IN 46123 Phone: 317-962-8067 Fax: 317-962-3796 | |
Dr. Drew A Kepple, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1351 Ronald Reagan Pkwy Ste B, Avon, IN 46123 Phone: 317-948-3200 Fax: 317-217-2424 | |
Kerry Lee Hensley, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7376 Business Center Dr, Suite A, Avon, IN 46123 Phone: 317-272-7887 Fax: 317-272-7888 | |
Dr. Jeffrey R Ihlendorf, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1115 N Ronald Reagan Pkwy, Suite 141, Avon, IN 46123 Phone: 317-948-3200 Fax: 317-217-2424 | |
Jennifer K Botkin, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8244 E Us Highway 36, Suite 210, Avon, IN 46123 Phone: 317-272-7337 Fax: 317-272-8534 | |
Callyn B. Riggs, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1111 Ronald Reagan Pkwy, B1100, Avon, IN 46123 Phone: 317-948-2700 Fax: 317-948-2959 |